Page last updated: 2024-09-05

sk&f 107260 and sb 223245

sk&f 107260 has been researched along with sb 223245 in 2 studies

Compound Research Comparison

Studies
(sk&f 107260)
Trials
(sk&f 107260)
Recent Studies (post-2010)
(sk&f 107260)
Studies
(sb 223245)
Trials
(sb 223245)
Recent Studies (post-2010) (sb 223245)
1100700

Protein Interaction Comparison

ProteinTaxonomysk&f 107260 (IC50)sb 223245 (IC50)
Integrin beta-3Homo sapiens (human)0.145
Integrin alpha-V Homo sapiens (human)0.145

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, FE; Callahan, JF; Calvo, RR; Huffman, WF; Hwang, SM; Keenan, RM; Kopple, KD; Kwon, C; Miller, WH; Peishoff, CE; Samanen, JM; Wong, AS; Yuan, CK1
Gottschalk, KE; Kessler, H; Lavecchia, A; Marinelli, L; Novellino, E1

Other Studies

2 other study(ies) available for sk&f 107260 and sb 223245

ArticleYear
Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
    Journal of medicinal chemistry, 1997, Jul-18, Volume: 40, Issue:15

    Topics: Binding Sites; Oligopeptides; Protein Conformation; Receptors, Vitronectin

1997
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.
    Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21

    Topics: Algorithms; Benzodiazepines; Crystallization; Crystallography, X-Ray; Drug Design; Hydrogen Bonding; Integrin alphaVbeta3; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Mutagenesis, Site-Directed; Oligopeptides; Protein Conformation; Stereoisomerism; Structure-Activity Relationship

2003